Ivantis Company
%20.jpg)
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
Investors
(INV)%20.jpg)
Total Funding:
$132.4M
Headquarters:
Irvine, California, United States
Funding Status:
Late Stage Venture
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series C
Technology:
P4 Medicine
Investor Type:
For Profit
Investors Number:
16
Founded Date:
2007-01-01
Industry:
Health Care, Health Diagnostics, Medical Device